Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
K2 Therapeutics Appoints Dr. Ying Huang As Chief Executive Officer
PRIVATEAug 11, 2026•about 3 hours ago
Position
Chief Executive Officer
Company
K2 Therapeutics
Dr. Ying Huang
SingaporeBiotechnology
Description
K2 Therapeutics has announced the appointment of Dr. Ying Huang as its Chief Executive Officer. The company, founded by MPM BioImpact, focuses on advancing biotechnology innovation with a global approach.
Company Information
Company
K2 Therapeutics
Location
Singapore
About
K2 Therapeutics is a Singapore-based biotech company focused on identifying and translating assets into medicines. Founded by MPM BioImpact, it aims to unlock potential in medicine to improve and extend lives. The company operates under a hub-and-spoke model to gain a competitive edge in the biotech industry.
Predictive Intelligence
Strategic
ML-powered predictions for K2 Therapeutics's next move